arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Rezolute, Inc.

RZLT Health Care Biotechnology: Pharmaceutical Preparations
$3.85
▲ +4.2% Today
as of Oct 23, 16:52 ET
Last 30 days -9.29% Sep 14 → Oct 23
$3.48 $3.85 $4.22 $4.60 $4.97 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$3.78
High
$3.94
Low
$3.70
Volume
$1M
Avg Vol
$3M
Mkt Cap
$424M
P/E (TTM)
—
Beta
—
52w High
$11.46
52w Low
$1.07
Div Yield
—
Shares Out
$96M

Recent Press Releases & News last 60 days · 13 items

Oct 14 · 20:05 PR GlobeNewswire
Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
Oct 6 · 09:28 MT Newswires
Cantor Fitzgerald Upgrades Rezolute to Overweight From Neutral
Oct 5 · 12:58 Stocktwits
Rezolute Gets FDA Nod For Pre-BLA Meeting Despite Phase 3 Miss — Retail Expects ‘Huge Rerating’
▸ Show all 13 press releases & news Free account →

RZLT earnings at a glance

Rezolute, Inc. (RZLT) is scheduled to report earnings on Thursday, November 5, 2026 — in 12 days. Analysts expect earnings per share of -$0.18, compared with -$0.18 in the same quarter last year (+0%). The options market is pricing a move of about ±26.6% after the report, a range of roughly $2.83 to $4.87 from today's $3.85. Over its last 6 reports the stock rose the next day 4 times and fell 2, moving ±5.2% on average; after the most recent report on Sep 24, 2026 it moved -1.0%. That means options currently expect more movement than RZLT has typically delivered. RZLT beat the consensus EPS estimate in 1 of its last 6 reported quarters. Implied volatility is currently 225%. The share price of $3.85 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.07
$11
27% of range
Avg surprise (last 6)
-17.6%
Avg reaction (last 6)
+3.2%
67% positive
Latest IV / EM
225%
EM ±26.6% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.34$-0.29$-0.24$-0.18$-0.13 Actual $-0.28Actual $-0.27Actual $-0.34Actual $-0.22Actual $-0.22Actual $-0.27Est $-0.22Actual $-0.26Est $-0.23Actual $-0.18Est $-0.27Actual $-0.22Actual $-0.22Est $-0.16Actual $-0.16Est $-0.13Actual $-0.20Est $-0.14 SepDecMarSepDecMar/2025Jun/2025Sep/2025Dec8KMar/20268K
Revenue vs Net Income Revenue Net income
$-23M$-21M$-19M$-18M$-16M Sep 24Dec 24Mar 25Sep 25Dec 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Sep 24, 20268K 2026-09-24 $-0.20 $-0.14 -42.9% — -1.0% earnings
Tue May 12, 2026Mar/2026 $-0.16 $-0.13 -23.1% +40.7% +0.9% earnings
Thu Feb 12, 20268K 2026-02-12 $-0.22 $-0.16 -37.5% — +5.8% earnings
Wed Dec 31, 2025Dec 2025 $-0.22 — — — — financials
Thu Nov 6, 2025Sep/2025 $-0.18 $-0.27 +33.3% — +12.1% earnings
Wed Sep 17, 2025Jun/2025 $-0.26 $-0.23 -13.0% — +6.4% earnings
Tue May 13, 2025Mar/2025 $-0.27 $-0.22 -22.7% — -4.9% earnings
Tue Dec 31, 2024Dec 2024 $-0.22 — — — — financials
Mon Sep 30, 2024Sep 2024 $-0.22 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.34 — — — — financials
Sun Dec 31, 2023Dec 2023 $-0.27 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.28 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.30 — — — — financials
Sat Dec 31, 2022Dec 2022 $-0.26 — — — — financials
Fri Sep 30, 2022Sep 2022 $-0.19 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Nov 5, 2026Sep/2026OTHER -$0.18-$0.18 0.0%

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-17M$-24M$-20M—$-20M$-17M$-17M—
Net income$-16M$-23M$-18M—$-19M$-16M$-15M—
EPS (diluted)$-0.16$-0.22$-0.18—$-0.27$-0.22$-0.22—

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$11M$12M$9M$94M$15M$9M$10M$70M
Inventory————————
Total current assets$122M$135M$155M$171M$89M$99M$110M$129M
Total assets$125M$139M$159M$175M$95M$112M$123M$133M
Long-term debt————————
Total liabilities$9M$11M$11M$13M$12M$12M$10M$12M
Total equity$117M$128M$147M$162M$83M$100M$113M$121M

Implied volatility — last 90 days

61%496%930%1365%1800% Jun 08 — IV 232% · EM ±30.6%Jun 09 — IV 633% · EM ±79.3%Jun 10 — IV 554% · EM ±65.4%Jun 11 — IV 611% · EM ±67.5%Jun 12 — IV 611% · EM ±62.5%Jun 15 — IV 350% · EM ±25.3%Jun 16 — IV 253% · EM ±15.0%Jun 17 — IV 335% · EM ±14.0%Jun 19 — IV 142% · EM ±31.4%Jun 22 — IV 98% · EM ±20.4%Jun 23 — IV 85% · EM ±17.4%Jun 24 — IV 99% · EM ±19.8%Jun 26 — IV 98% · EM ±18.8%Jun 29 — IV 108% · EM ±19.1%Jun 30 — IV 107% · EM ±18.3%Jul 01 — IV 109% · EM ±18.2%Jul 02 — IV 176% · EM ±28.5%Jul 03 — IV 179% · EM ±28.0%Jul 06 — IV 113% · EM ±15.7%Jul 07 — IV 132% · EM ±17.4%Jul 08 — IV 185% · EM ±23.2%Jul 09 — IV 107% · EM ±12.7%Jul 10 — IV 176% · EM ±19.5%Jul 13 — IV 139% · EM ±11.6%Jul 14 — IV 658% · EM ±47.6%Jul 15 — IV 196% · EM ±11.6%Jul 16 — IV 712% · EM ±29.7%Jul 20 — IV 117% · EM ±27.5%Jul 21 — IV 109% · EM ±25.4%Jul 22 — IV 109% · EM ±25.0%Jul 23 — IV 122% · EM ±27.4%Jul 24 — IV 113% · EM ±25.1%Jul 27 — IV 87% · EM ±18.2%Jul 28 — IV 107% · EM ±21.9%Jul 29 — IV 96% · EM ±19.2%Jul 30 — IV 68% · EM ±13.3%Jul 31 — IV 161% · EM ±30.7%Aug 03 — IV 86% · EM ±15.2%Aug 04 — IV 140% · EM ±24.2%Aug 05 — IV 109% · EM ±18.2%Aug 06 — IV 230% · EM ±37.2%Aug 07 — IV 61% · EM ±9.6%Aug 10 — IV 147% · EM ±20.3%Aug 11 — IV 139% · EM ±18.4%Aug 12 — IV 259% · EM ±32.4%Aug 13 — IV 451% · EM ±53.3%Aug 14 — IV 123% · EM ±13.6%Aug 17 — IV 230% · EM ±19.2%Aug 18 — IV 297% · EM ±21.5%Aug 19 — IV 233% · EM ±13.8%Aug 20 — IV 1233% · EM ±51.5%Aug 24 — IV 124% · EM ±25.9%Aug 25 — IV 180% · EM ±36.9%Aug 26 — IV 109% · EM ±21.8%Aug 27 — IV 133% · EM ±26.1%Aug 28 — IV 124% · EM ±23.8%Aug 31 — IV 205% · EM ±36.2%Sep 01 — IV 368% · EM ±63.3%Sep 02 — IV 394% · EM ±65.8%Sep 03 — IV 163% · EM ±26.4%Sep 04 — IV 283% · EM ±44.2%Sep 07 — IV 319% · EM ±44.2%Sep 08 — IV 176% · EM ±23.3%Sep 09 — IV 329% · EM ±41.3%Sep 10 — IV 330% · EM ±39.0%Sep 11 — IV 504% · EM ±55.7%Sep 14 — IV 493% · EM ±41.2%Sep 15 — IV 716% · EM ±51.8%Sep 16 — IV 1440% · EM ±85.0%Sep 17 — IV 1800% · EM ±75.2%Sep 21 — IV 216% · EM ±45.2%Sep 22 — IV 215% · EM ±43.9%Sep 23 — IV 318% · EM ±63.8%Sep 24 — IV 259% · EM ±50.8%Sep 25 — IV 338% · EM ±64.7%Sep 28 — IV 230% · EM ±40.7%Sep 29 — IV 348% · EM ±59.9%Sep 30 — IV 249% · EM ±41.7%Oct 01 — IV 663% · EM ±107.3%Oct 02 — IV 291% · EM ±45.5%Oct 05 — IV 502% · EM ±69.5%Oct 06 — IV 342% · EM ±45.1%Oct 07 — IV 269% · EM ±33.7%Oct 08 — IV 225% · EM ±26.6%

Sector peers

DMAC
DiaMedica Therapeutics Inc.
$450M $8.72+0.3%
TTRX
Turn Therapeutics Inc.
$396M $10.28+1.3%
RLMD
Relmada Therapeutics, Inc.
$390M $3.27+1.9%
EVMN
Evommune, Inc.
$472M $5.10-1.4%
EBS
Emergent BioSolutions Inc.
$363M $6.23+0.5%
ARVN
Arvinas, Inc.
$487M $7.30-3.4%

RZLT earnings FAQ

When is RZLT's next earnings date?

Rezolute, Inc. is expected to report on November 5, 2026.

What is RZLT's expected move for earnings?

Options currently price a move of about ±26.6%, or $1.02 per share either way from $3.85.

How does RZLT stock usually react to earnings?

Across the last 6 reports the average next-day move was ±5.2%, up 4 times and down 2 times.

What EPS are analysts expecting from Rezolute, Inc.?

The consensus estimate is -$0.18 per share, versus -$0.18 a year ago.

What is RZLT's implied volatility?

RZLT's at-the-money implied volatility is about 225% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in